These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37094652)

  • 41. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
    Bomstein Y; Rozenblat S
    J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.
    Berth-Jones J; Damstra RJ; Golsch S; Livden JK; Van Hooteghem O; Allegra F; Parker CA;
    BMJ; 2003 Jun; 326(7403):1367. PubMed ID: 12816824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
    Gooderham M; Kircik L; Zirwas M; Lee M; Kempers S; Draelos Z; Ferris L; Jones T; Saint-Cyr Proulx E; Bissonnette R; Bhatia N; Koppel R; Guenthner S; Eads K; Welgus H; Merritt C; Elias M; Navale L; Higham R; Droege M; Berk D
    J Drugs Dermatol; 2023 Feb; 22(2):139-147. PubMed ID: 36745371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial.
    Saeki H; Ito K; Yokota D; Tsubouchi H
    J Am Acad Dermatol; 2022 Mar; 86(3):607-614. PubMed ID: 34710557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.
    Nakagawa H; Nemoto O; Igarashi A; Saeki H; Kabashima K; Oda M; Nagata T
    J Am Acad Dermatol; 2021 Oct; 85(4):854-862. PubMed ID: 34118298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Lee YW; Won CH; Jung K; Nam HJ; Choi G; Park YH; Park M; Kim B
    Br J Dermatol; 2019 May; 180(5):1030-1038. PubMed ID: 30623408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of skin barrier emulsion cream vs a conventional moisturizer on transepidermal water loss and corneometry in atopic dermatitis: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1482-4. PubMed ID: 25607793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
    Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
    J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single-center, randomized, controlled study on the efficacy of niacinamide-containing body emollients combined with cleansing gel in the treatment of mild atopic dermatitis.
    Zhu JR; Wang J; Wang SS
    Skin Res Technol; 2023 Sep; 29(9):e13475. PubMed ID: 37753690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The improvement of infantile atopic dermatitis during the maintenance period: A multicenter, randomized, parallel controlled clinical study of emollients in Prinsepia utilis Royle.
    Wang S; Wang L; Li P; Shu H; Shen C; Wu Y; Luo Z; Miao L; Wang H; Jiao L; Tian J; Peng X; Zhao M; Liu Y; Nie X; He L; Ma L
    Dermatol Ther; 2020 Mar; 33(2):e13153. PubMed ID: 31705602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
    Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
    Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab.
    Tong Z; Zhang Y; Zhou K; Zou Y; Wu Z; Chen J; Zhuang Z; Zhao Y; Gong T; Ji C
    J Am Acad Dermatol; 2023 Oct; 89(4):826-828. PubMed ID: 37307992
    [No Abstract]   [Full Text] [Related]  

  • 54. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
    Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J
    Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
    Kim BS; Sun K; Papp K; Venturanza M; Nasir A; Kuligowski ME
    J Am Acad Dermatol; 2020 Jun; 82(6):1305-1313. PubMed ID: 32057960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND).
    Shi VY; Bhutani T; Fonacier L; Deleuran M; Shumack S; Valdez H; Zhang F; Chan GL; Cameron MC; Yin NC
    J Am Acad Dermatol; 2022 Aug; 87(2):351-358. PubMed ID: 35439608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
    Simpson EL; Papp KA; Blauvelt A; Chu CY; Hong HC; Katoh N; Calimlim BM; Thyssen JP; Chiou AS; Bissonnette R; Stein Gold LF; Wegzyn C; Hu X; Liu M; Liu J; Tenorio AR; Chu AD; Guttman-Yassky E
    JAMA Dermatol; 2022 Apr; 158(4):404-413. PubMed ID: 35262646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Meysami M; Hashempur MH; Kamalinejad M; Emtiazy M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1673-1678. PubMed ID: 33100212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bath emollients for atopic eczema: why use them?
    Drug Ther Bull; 2007 Oct; 45(10):73-5. PubMed ID: 17928284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.